Company / Gross Margin
Lexaria Bioscience Corp. Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
99.0%
FY2025
5-year range
68.4% / 99.0%
FY2021-FY2025
Trend
+15.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin has fluctuated over the past 9 years, ranging from -103.3% in FY2016 to 99.0% in FY2025.
Based on SEC 10-K filings.
99.0% in FY2025 with a 5-year CAGR of +9.2%.
Improved from 71.9% to 99.0% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- +23.2pp
- 5-Year Change
- +9.2pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin increased 15.0% year-over-year.
- Lowest gross margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 99.0% | +15.0% |
| FY2024 | 86.1% | +19.8% |
| FY2023 | 71.9% | -5.1% |
| FY2022 | 75.7% | +10.7% |
| FY2021 | 68.4% | -23.7% |
| FY2020 | 89.7% | -4.7% |
| FY2019 | 94.2% | +883.0% |
| FY2017 | -12.0% | +88.3% |
| FY2016 | -103.3% | - |
| FY2015 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026